A 62-year-old woman with no medical problems and no medications has office blood pressures of 137/84, 144/85, 146/84, and 138/84, while ambulatory monitoring shows normal daytime, nighttime, and 24‑hour averages. What is the most likely diagnosis?

White Coat Hypertension

This patient has white coat hypertension, defined by consistently elevated office blood pressures (137-146/84-85 mmHg) but normal ambulatory blood pressure monitoring showing 24-hour average of 122/72 mmHg, daytime 124/78 mmHg, and nighttime 118/68 mmHg 1.

Diagnostic Criteria Applied

The diagnosis is straightforward when applying current guideline thresholds:

Office BP measurements:

• All four readings range from 137-146/84-85 mmHg
• Consistently meet hypertension criteria (≥130/80 mmHg by ACC/AHA or ≥140/90 mmHg by ESH/ESC)

Ambulatory BP monitoring (the definitive test):

• 24-hour average: 122/72 mmHg (normal: <130/80 mmHg) 2, 3
• Daytime average: 124/78 mmHg (normal: <135/85 mmHg) 2, 3
• Nighttime average: 118/68 mmHg (normal: <120/70 mmHg) 2, 3

All ambulatory readings fall well below hypertension thresholds, confirming the discordance between office and out-of-office measurements that defines white coat hypertension 2.

Clinical Significance and Management

White coat hypertension carries intermediate cardiovascular risk between true normotension and sustained hypertension 2, 4. However, compared to sustained hypertensives, these patients have:

• Similar cardiovascular event rates to low-risk normotensive individuals when other risk factors are absent 5
• Higher out-of-office BP than true normotensives 2
• Increased risk of metabolic abnormalities and progression to sustained hypertension 2

Antihypertensive drug therapy is NOT indicated for this patient 5, 4. The available evidence shows that pharmacologic treatment in white coat hypertension does not modify ambulatory BP or reduce cardiovascular risk 5.

Recommended Approach

1. Confirm the diagnosis within 3-6 months with repeat out-of-office BP measurements 2

2. Implement lifestyle modifications including dietary changes, weight management if needed, regular physical activity, and sodium restriction 1

3. Close monitoring schedule:

   • Repeat ambulatory or home BP monitoring every 3-6 months 2
   • Screen for metabolic risk factors (diabetes, dyslipidemia) 2
   • Assess for end-organ damage (ECG, consider echocardiogram for left ventricular hypertrophy) 1

4. Watch for progression to sustained hypertension, which occurs more frequently in white coat hypertensives than true normotensives 2

Common Pitfalls to Avoid

Do not treat based solely on office readings in this scenario. The ACC/AHA guidelines explicitly state that out-of-office BP measurements should guide treatment decisions when discordance exists 1. Treating white coat hypertension exposes patients to medication side effects without cardiovascular benefit 5.

Ensure proper office BP measurement technique was used, as most measurement errors (wrong cuff size, unsupported arm, full bladder, legs crossed) artificially elevate readings 1. However, even with perfect technique, white coat hypertension occurs in 10-30% of patients with elevated office readings 4.

Recognize that ambulatory BP monitoring is superior to office measurements for predicting cardiovascular outcomes and end-organ damage 2. When office and ambulatory readings conflict, the ambulatory readings should take precedence for diagnosis and treatment decisions.